ASK REDCHAT ANYTHING ABOUT CALCIMEDICA INC.
CalciMedica Inc. (NASDAQ: CALC)
Listen to this Section
$0.72
+0.0165
(
+2.34% )
141.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Auxora™DetailsAcute Pancreatitis |
Phase 2b |
| Auxora™DetailsAsparaginase-induced pancreatic toxicity |
Phase 2 |
| Auxora™DetailsAcute Kidney Injury, Kidney disease |
Phase 2 |
| GB-102 (Pan-VEGF inhibitor)DetailsEye disease , Wet age-related macular degeneration , Age-related macular degeneration |
Failed |
| GB-102 (Pan-VEGF inhibitor)DetailsDiabetes, Eye disease , Diabetic macular edema |
Failed |
Market Data
|
| Open |
$0.72 |
| Previous Close |
$0.70 |
| Volume |
141.1K |
| Market Cap |
$11.13M |
| Day Range |
$0.69 - $0.73 |
| 52 Week Range |
$0.46 - $7.20 |
| Shares Outstanding |
15.80M |
| Change % |
+2.34% |
| Net Change |
▲ 0.0165 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-376,293.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-01-25 |
Sale |
-68314.00 |
WILSON ROBERT N |
| 2024-01-25 |
Buy |
243356.00 |
Sanderling Venture Partners VI LP |
| 2024-01-25 |
Buy |
243356.00 |
MIDDLETON FRED A |
| 2023-12-13 |
Buy |
506.00 |
WILSON ROBERT N |
| 2023-11-08 |
Buy |
2400.00 |
Roberts Eric W |
| 2023-11-08 |
Buy |
2000.00 |
Leheny A. Rachel |
| 2023-11-07 |
Buy |
36000.00 |
Hebbar Sudarshan |
| 2023-11-07 |
Buy |
2440.00 |
Leheny A. Rachel |
| 2023-11-07 |
Buy |
3700.00 |
Roberts Eric W |
| 2023-11-06 |
Buy |
3200.00 |
Roberts Eric W |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 8-k |
8K-related |
11 |
Mar 18, 2026 |
| 10-k |
Annual reports |
102 |
Mar 03, 2026 |
| s-3 |
Registration statements |
20 |
Mar 03, 2026 |
| 8-k |
8K-related |
12 |
Mar 03, 2026 |